Physician profile
Ryan Huntsman
NPI 1609281534
$2,690.05
in general payments reported to CMS, 2019-2025
26 companies · $50.46 in 2025
The $50.46 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $963 · 2020: $474 · 2021: $462 · 2022: $429 · 2023: $311 · 2025: $50.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $361.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $997.50 | 2019-2023 | Trigen, Evos, Bone Anchors With Arthroscopic Delivery System |
| Integra Lifesciences Corporation | $506.73 | 2019-2022 | |
| Horizon Therapeutics Plc | $180.62 | 2019-2021 | |
| Stryker Corporation | $165.64 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $150.18 | 2020-2023 | Nuzyra |
| Innovation Technologies INC | $134.50 | 2021-2023 | Irrisept |
| Medtronic Vascular, INC. | $115.77 | 2019 | |
| Bioventus LLC | $55.73 | 2020-2022 | |
| Organogenesis INC. | $50.46 | 2025 | Simplimax |
| Zyla Life Sciences, INC. | $36.71 | 2019-2020 | |
| Kci USA, INC. | $35.26 | 2021 | |
| Wright Medical Technology, INC. | $33.26 | 2020 | |
| Grt US Holding, INC. | $26.47 | 2022 | |
| Triad Life Sciences INC. | $23.50 | 2022 | |
| Misonix INC | $20.55 | 2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nabriva Therapeutics, Plc | $18.21 | 2022 | |
| Reapplix INC. | $16.53 | 2022 | |
| Polarityte, INC. | $16.13 | 2020 | |
| Collegium Pharmaceutical, INC. | $15.52 | 2022 | |
| Assertio Therapeutics, INC. | $15.40 | 2020 | |
| Paragon 28, INC. | $15.18 | 2019 | |
| Hikma Pharmaceuticals USA | $12.57 | 2022 | |
| Aroa Biosurgery Incorporated | $12.18 | 2022 | |
| Osiris Therapeutics INC. | $11.94 | 2019 | |
| Arteriocyte Medical Systems, INC. | $11.82 | 2021 | |
| Zimmer Biomet Holdings, INC. | $11.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Huntsman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.